skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells

Calura, E ; Pizzini, S ; Bisognin, A ; Coppe, A ; Sales, G ; Gaffo, E ; Fanelli, T ; Mannarelli, C ; Zini, R ; Norfo, R ; Pennucci, V ; Manfredini, R ; Romualdi, C ; Guglielmelli, P ; Vannucchi, A M ; Bortoluzzi, S

Blood cancer journal (New York), 2016-06, Vol.6 (6), p.e439-e439 [Periódico revisado por pares]

United States: Springer Nature B.V

Texto completo disponível

Citações Citado por
2
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study

Rigacci, Luigi ; Puccini, Bendetta ; Dodero, Anna ; Iacopino, Pasquale ; Castagna, Luca ; Bramanti, Stefania ; Ciceri, Fabio ; Fanin, Renato ; Rambaldi, Alessandro ; Falda, Michele ; Milone, Giuseppe ; Guidi, Stefano ; Martelli, Massimo Fabrizio ; Mazza, Patrizio ; Oneto, Rosi ; Bosi, Alberto

Annals of hematology, 2012-06, Vol.91 (6), p.931-939 [Periódico revisado por pares]

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por
3
Antibodies to tissue transglutaminase C in Type I diabetes
Antibodies to tissue transglutaminase C in Type I diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antibodies to tissue transglutaminase C in Type I diabetes

LAMPASONA, V ; BONFANTI, R ; BAZZIGALUPPI, E ; VENERANDO, A ; CHIUMELLO, G ; BOSI, E ; BONIFACIO, E

Diabetologia, 1999-10, Vol.42 (10), p.1195-1198 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível

Citações Citado por
4
Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy
Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antihypertensive efficacy and tolerability of candesartan-hydrochlorothiazide 32/12.5 mg and 32/25 mg in patients not optimally controlled with candesartan monotherapy

Bönner, Gerd

Blood pressure, 2008, Vol.17 (s2), p.22-30 [Periódico revisado por pares]

Sweden: Informa UK Ltd

Texto completo disponível

Citações Citado por
5
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Cavo, Michele, Prof ; Tacchetti, Paola, MD ; Patriarca, Francesca, MD ; Petrucci, Maria Teresa, MD ; Pantani, Lucia, MD ; Galli, Monica, MD ; Di Raimondo, Francesco, Prof ; Crippa, Claudia, MD ; Zamagni, Elena, MD ; Palumbo, Antonio, MD ; Offidani, Massimo, MD ; Corradini, Paolo, Prof ; Narni, Franco, MD ; Spadano, Antonio, MD ; Pescosta, Norbert, MD ; Deliliers, Giorgio Lambertenghi, Prof ; Ledda, Antonio, MD ; Cellini, Claudia, MD ; Caravita, Tommaso, MD ; Tosi, Patrizia, MD ; Baccarani, Michele, Prof

The Lancet (British edition), 2010-12, Vol.376 (9758), p.2075-2085 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

Hochhaus, Andreas ; Gambacorti-Passerini, Carlo ; Abboud, Camille ; Gjertsen, Bjørn Tore ; Brümmendorf, Tim H ; Smith, B Douglas ; Ernst, Thomas ; Giraldo-Castellano, Pilar ; Olsson-Strömberg, Ulla ; Saussele, Susanne ; Bardy-Bouxin, Nathalie ; Viqueira, Andrea ; Leip, Eric ; Russell-Smith, T Alexander ; Leone, Jocelyn ; Rosti, Gianantonio ; Watts, Justin ; Giles, Francis J

Leukemia, 2020-08, Vol.34 (8), p.2125-2137 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

Antonioli, E ; Guglielmelli, P ; Pancrazzi, A ; Bogani, C ; Verrucci, M ; Ponziani, V ; Longo, G ; Bosi, A ; Vannucchi, A M

Leukemia, 2005-10, Vol.19 (10), p.1847-1849 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)

AOUDJHANE, M ; LABOPIN, M ; SHOUTEN, H ; BLAISE, D ; FALDA, M ; FAUSER, A. A ; ESTEVE, J ; POLGE, E ; SLAVIN, S ; NIEDERWIESER, D ; NAGLER, A ; ROCHA, V ; GORIN, N. C ; SHIMONI, A ; RUUTU, T ; KOLB, H.-J ; FRASSONI, F ; BOIRON, J. M ; YIN, J. L ; FINKE, J

Leukemia, 2005-12, Vol.19 (12), p.2304-2312 [Periódico revisado por pares]

London: Nature Publishing

Texto completo disponível

Citações Citado por
9
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

Ruggeri, A ; Labopin, M ; Sanz, G ; Piemontese, S ; Arcese, W ; Bacigalupo, A ; Blaise, D ; Bosi, A ; Huang, H ; Karakasis, D ; Koc, Y ; Michallet, M ; Picardi, A ; Sanz, J ; Santarone, S ; Sengelov, H ; Sierra, J ; Vincent, L ; Volt, F ; Nagler, A ; Gluckman, E ; Ciceri, F ; Rocha, V ; Mohty, M

Leukemia, 2015-09, Vol.29 (9), p.1891-1900 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Palumbo, Antonio ; Chanan-Khan, Asher ; Weisel, Katja ; Nooka, Ajay K ; Masszi, Tamas ; Beksac, Meral ; Spicka, Ivan ; Hungria, Vania ; Munder, Markus ; Mateos, Maria V ; Mark, Tomer M ; Qi, Ming ; Schecter, Jordan ; Amin, Himal ; Qin, Xiang ; Deraedt, William ; Ahmadi, Tahamtan ; Spencer, Andrew ; Sonneveld, Pieter

The New England journal of medicine, 2016-08, Vol.375 (8), p.754-766 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (37)

Data de Publicação 

De até
Refinar
  1. Antes de2004  (4)
  2. 2004Até2007  (5)
  3. 2008Até2011  (15)
  4. 2012Até2016  (12)
  5. Após 2016  (3)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.